$75.48
0.660.88%
Last update: 10:54 AM
15 minutes delayed
Haemonetics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Haemonetics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $1.02 | $1.00 | 2.00 % |
Mar 2024 | 2024-05-09 | $0.90 | $0.89 | 1.12 % |
Dec 2023 | 2024-02-08 | $1.04 | $0.94 | 10.6 % |
Sep 2023 | 2023-11-02 | $0.99 | $0.89 | 11.2 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $336.17M | $335.38M | 0.24 % |
Mar 2024 | 2024-05-09 | $343.29M | $329.11M | 4.31 % |
Dec 2023 | 2024-02-08 | $336.25M | $320.29M | 4.98 % |
Sep 2023 | 2023-11-02 | $318.18M | $313.12M | 1.62 % |
Haemonetics (HAE) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 8, 2024 for Q1.
The Actual EPS was $1.02, which beat the estimate of $1.00.
The Actual Revenue was $336.2M, which beat the estimate of $335.4M.
Browse earnings estimates, EPS, and revenue on all stocks.